Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
| 대상 질환 | Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | University of Michigan |
| 상태 | 완료 |
| 참여자 수 | 306 명 |
| 중재(약물) | New-prescription Alert, New-prescription Alert with referral option, Existing-prescription notification to prescriber, Existing-prescription notification to pharmacist |
| 시작일 | 2022년 8월 1일 |
| 완료일 | 2024년 12월 15일 |
| 결과 공개일 | 2026년 3월 30일 |
요약
The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors. Findings from this project will establish a framework for implementing prescriber-pharmacist collaboration for high risk medications, including anticoagulants
The Number (Proportion) of Notifications (in the Existing-prescription Notification Conditions) That Are Addressed Within 7 Days.
| Notification Sent to Prescriber | 24.86 percent of notifications |
|---|---|
| Notification Sent to Pharmacist | 21.74 percent of notifications |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomati — Insel Gruppe AG, University Hospital Bern
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University
- Amplatzer Amulet China Post Market Study (PMS) — Abbott Medical Devices
- Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmia — Oxford University Hospitals NHS Trust
- Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation — Massachusetts General Hospital
- Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With N — Intermountain Health Care, Inc.